Shortness of Breath

Shortness Of Breath — scientific infographic poster
Anatomical cross-section illustrating organs affected by Shortness of Breath
Anatomical cross-section illustrating organs affected by Shortness of Breath.
Microscopic view of Shortness of Breath cellular pathology
Microscopic view of Shortness of Breath cellular pathology.
Medical visualization of Shortness of Breath clinical presentation
Medical visualization of Shortness of Breath clinical presentation.

Table of Contents

  1. Overview
  2. Types of Dyspnea
  3. Common Causes
  4. Mechanisms
  5. Evaluation
  6. Management
  7. When to Seek Medical Care
  8. Connections
  9. References & Research
  10. Featured Videos

Overview

Shortness of breath — or dyspnea — is the subjective experience of breathing discomfort. It is one of the most common reasons for ambulance calls and ER visits, and a frequent reason adults stop exercising before they realize anything is wrong with their heart or lungs. Like chest pain, dyspnea can mean almost anything — deconditioning, anemia, anxiety, asthma, heart failure, pulmonary embolism, ILD, or cancer — and the workup is layered: a quick set of bedside vitals and an ECG narrow it down at the bedside, with imaging and pulmonary function tests filling in the rest.

Types of Dyspnea

Common Causes

Mechanisms

Evaluation

Management

When to Seek Medical Care

Connections


References & Research

Historical Background

The systematic taxonomy of dyspnea began with William Harvey's 17th-century circulation work and was refined by 20th-century physiologists. The MRC dyspnea scale (1959) and the Borg scale (1982) standardized symptom reporting; cardiopulmonary exercise testing in the 1980s let clinicians separate ventilatory, cardiac, and gas-exchange limitations.

Key Research Papers

  1. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. American Journal of Respiratory and Critical Care Medicine. 2012;185(4):435-452.
  2. Mahler DA, O'Donnell DE. Recent advances in dyspnea. Chest. 2015;147(1):232-241.
  3. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. New England Journal of Medicine. 2002;347(3):161-167.
  4. Konstantinides SV, Meyer G. The 2019 ESC guidelines on acute pulmonary embolism. European Heart Journal. 2019;40(42):3453-3455.
  5. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. American Journal of Respiratory and Critical Care Medicine. 2013;188(8):e13-e64.
  6. Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. New England Journal of Medicine. 2014;370(22):2071-2082.
  7. Currow DC, McDonald C, Oaten S, et al. Once-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance study. Journal of Pain and Symptom Management. 2011;42(3):388-399.
  8. Coccia CB, Palkowski GH, Schweitzer B, Motsohi T, Ntusi NA. Dyspnoea: pathophysiology and a clinical approach. South African Medical Journal. 2016;106(1):32-36.
  9. Berliner D, Schneider N, Welte T, Bauersachs J. The differential diagnosis of dyspnea. Deutsches Ärzteblatt International. 2016;113(49):834-845.
  10. Banzett RB, Schwartzstein RM. Dyspnea: don't just look, ask! American Journal of Respiratory and Critical Care Medicine. 2015;192(12):1404-1405.

PubMed Topic Searches

  1. Dyspnea evaluation
  2. BNP and heart-failure diagnosis
  3. Cardiopulmonary exercise testing for dyspnea
  4. Pulmonary rehabilitation in COPD
  5. Opioids for refractory dyspnea
  6. Vocal-cord dysfunction

Back to Table of Contents